COPART INC (CPRT)

US2172041061 - Common Stock

58.22  -0.23 (-0.39%)

Premarket: 58.22 0 (0%)

Fundamental Rating

6

Overall CPRT gets a fundamental rating of 6 out of 10. We evaluated CPRT against 83 industry peers in the Commercial Services & Supplies industry. CPRT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, CPRT is valued expensive at the moment. These ratings could make CPRT a good candidate for quality investing.



8

1. Profitability

1.1 Basic Checks

CPRT had positive earnings in the past year.
In the past year CPRT had a positive cash flow from operations.
CPRT had positive earnings in each of the past 5 years.
Each year in the past 5 years CPRT had a positive operating cash flow.

1.2 Ratios

CPRT's Return On Assets of 15.70% is amongst the best of the industry. CPRT outperforms 95.18% of its industry peers.
CPRT's Return On Equity of 17.64% is amongst the best of the industry. CPRT outperforms 80.72% of its industry peers.
CPRT has a better Return On Invested Capital (15.44%) than 86.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPRT is significantly above the industry average of 10.07%.
Industry RankSector Rank
ROA 15.7%
ROE 17.64%
ROIC 15.44%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.78%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%

1.3 Margins

CPRT has a better Profit Margin (31.92%) than 97.59% of its industry peers.
CPRT's Profit Margin has improved in the last couple of years.
CPRT's Operating Margin of 36.28% is amongst the best of the industry. CPRT outperforms 100.00% of its industry peers.
CPRT's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 44.81%, CPRT is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
CPRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 36.28%
PM (TTM) 31.92%
GM 44.81%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CPRT is creating value.
The number of shares outstanding for CPRT has been increased compared to 1 year ago.
Compared to 5 years ago, CPRT has more shares outstanding
CPRT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 37.30 indicates that CPRT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 37.30, CPRT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for CPRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 37.3
ROIC/WACC1.69
WACC9.16%

2.3 Liquidity

A Current Ratio of 6.62 indicates that CPRT has no problem at all paying its short term obligations.
CPRT's Current ratio of 6.62 is amongst the best of the industry. CPRT outperforms 95.18% of its industry peers.
A Quick Ratio of 6.55 indicates that CPRT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 6.55, CPRT belongs to the best of the industry, outperforming 97.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.62
Quick Ratio 6.55

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.58% over the past year.
The Earnings Per Share has been growing slightly by 4.32% on average over the past years.
CPRT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.17%.
The Revenue has been growing by 15.72% on average over the past years. This is quite good.
EPS 1Y (TTM)5.58%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%8.82%
Revenue 1Y (TTM)9.17%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%12.39%

3.2 Future

Based on estimates for the next years, CPRT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.08% on average per year.
The Revenue is expected to grow by 11.43% on average over the next years. This is quite good.
EPS Next Y14.15%
EPS Next 2Y13.63%
EPS Next 3Y14.17%
EPS Next 5Y12.08%
Revenue Next Year10.38%
Revenue Next 2Y10.01%
Revenue Next 3Y10.95%
Revenue Next 5Y11.43%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

CPRT is valuated quite expensively with a Price/Earnings ratio of 41.00.
The rest of the industry has a similar Price/Earnings ratio as CPRT.
The average S&P500 Price/Earnings ratio is at 27.20. CPRT is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 32.44, the valuation of CPRT can be described as expensive.
CPRT's Price/Forward Earnings ratio is in line with the industry average.
CPRT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41
Fwd PE 32.44

4.2 Price Multiples

67.47% of the companies in the same industry are cheaper than CPRT, based on the Enterprise Value to EBITDA ratio.
CPRT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 56.43
EV/EBITDA 29.36

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPRT does not grow enough to justify the current Price/Earnings ratio.
CPRT has an outstanding profitability rating, which may justify a higher PE ratio.
CPRT's earnings are expected to grow with 14.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.9
PEG (5Y)9.49
EPS Next 2Y13.63%
EPS Next 3Y14.17%

0

5. Dividend

5.1 Amount

CPRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COPART INC

NASDAQ:CPRT (12/20/2024, 8:03:47 PM)

Premarket: 58.22 0 (0%)

58.22

-0.23 (-0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-21 2024-11-21/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners84.98%
Inst Owner Change0.65%
Ins Owners9.19%
Ins Owner Change0%
Market Cap56.10B
Analysts78.82
Price Target60.78 (4.4%)
Short Float %1.42%
Short Ratio2.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.95%
Min EPS beat(2)-10.92%
Max EPS beat(2)-0.98%
EPS beat(4)0
Avg EPS beat(4)-4.85%
Min EPS beat(4)-10.92%
Max EPS beat(4)-0.84%
EPS beat(8)4
Avg EPS beat(8)0.06%
EPS beat(12)7
Avg EPS beat(12)-0.75%
EPS beat(16)10
Avg EPS beat(16)2.35%
Revenue beat(2)1
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)2.21%
Revenue beat(4)2
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-3.08%
Max Revenue beat(4)2.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.81%
PT rev (1m)3.47%
PT rev (3m)0.05%
EPS NQ rev (1m)-1.34%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0.57%
EPS NY rev (3m)-4.05%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.06%
Revenue NY rev (1m)2.99%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 41
Fwd PE 32.44
P/S 12.86
P/FCF 56.43
P/OCF 35.51
P/B 7.1
P/tB 7.67
EV/EBITDA 29.36
EPS(TTM)1.42
EY2.44%
EPS(NY)1.79
Fwd EY3.08%
FCF(TTM)1.03
FCFY1.77%
OCF(TTM)1.64
OCFY2.82%
SpS4.53
BVpS8.2
TBVpS7.59
PEG (NY)2.9
PEG (5Y)9.49
Profitability
Industry RankSector Rank
ROA 15.7%
ROE 17.64%
ROCE 19.41%
ROIC 15.44%
ROICexc 28.26%
ROICexgc 32.54%
OM 36.28%
PM (TTM) 31.92%
GM 44.81%
FCFM 22.78%
ROA(3y)18.36%
ROA(5y)19.17%
ROE(3y)20.78%
ROE(5y)23.4%
ROIC(3y)19.15%
ROIC(5y)20.04%
ROICexc(3y)30.14%
ROICexc(5y)28.88%
ROICexgc(3y)50.08%
ROICexgc(5y)42.59%
ROCE(3y)24.07%
ROCE(5y)25.2%
ROICexcg growth 3Y-0.59%
ROICexcg growth 5Y-0.42%
ROICexc growth 3Y-0.76%
ROICexc growth 5Y0.83%
OM growth 3Y-4.2%
OM growth 5Y1.12%
PM growth 3Y-2.57%
PM growth 5Y2.11%
GM growth 3Y-3.25%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 290.18%
Cap/Sales 13.42%
Interest Coverage 520.56
Cash Conversion 88.5%
Profit Quality 71.39%
Current Ratio 6.62
Quick Ratio 6.55
Altman-Z 37.3
F-Score5
WACC9.16%
ROIC/WACC1.69
Cap/Depr(3y)278.5%
Cap/Depr(5y)355.84%
Cap/Sales(3y)11.68%
Cap/Sales(5y)15.82%
Profit Quality(3y)72.01%
Profit Quality(5y)63.79%
High Growth Momentum
Growth
EPS 1Y (TTM)5.58%
EPS 3Y-9.17%
EPS 5Y4.32%
EPS Q2Q%8.82%
EPS Next Y14.15%
EPS Next 2Y13.63%
EPS Next 3Y14.17%
EPS Next 5Y12.08%
Revenue 1Y (TTM)9.17%
Revenue growth 3Y16.31%
Revenue growth 5Y15.72%
Sales Q2Q%12.39%
Revenue Next Year10.38%
Revenue Next 2Y10.01%
Revenue Next 3Y10.95%
Revenue Next 5Y11.43%
EBIT growth 1Y0.8%
EBIT growth 3Y11.42%
EBIT growth 5Y17.02%
EBIT Next Year19.03%
EBIT Next 3Y15.28%
EBIT Next 5Y13.9%
FCF growth 1Y32.5%
FCF growth 3Y22.13%
FCF growth 5Y28.66%
OCF growth 1Y34.35%
OCF growth 3Y14.12%
OCF growth 5Y17.89%